Accéder au contenu
Merck

β-Hemolytic streptococcal throat carriage and tonsillopharyngitis: a cross-sectional prevalence study in Gabon, Central Africa.

Infection (2014-11-29)
Sabine Bélard, Nicole Toepfner, Benjamin Arnold, Abraham Sunday Alabi, Reinhard Berner
RÉSUMÉ

Group A streptococcus (GAS) and possibly other β-hemolytic streptococci (BHS) account for a considerable morbidity and mortality burden in African populations; however, disproportionately little is known about the epidemiology of BHS in sub-Saharan Africa. This study assessed the prevalence of GAS, group G streptococcus (GGS) and group C streptococcus (GCS) carriage and tonsillopharyngitis in a Central African population. A prospective cross-sectional study was performed to assess the prevalence of and risk factors for BHS carrier status and tonsillopharyngitis in children and adults in Gabon. The overall BHS carrier prevalence was 135/1,005 (13.4%); carrier prevalence of GAS, GGS, and GCS was 58/1,005 (5.8%), 50/1,005 (5.0%), and 32/1,005 (3.2%), respectively. Streptococcal carriage was associated with school and pre-school age (adjusted OR 2.65, 95% CI 1.62-4.36, p = 0.0001 and 1.90, 95% CI 1.14-3.17, p = 0.0141, respectively). Participants residing in urban areas were less likely carriers (OR 0.52, p = 0.0001). The point-prevalence of BHS-positive tonsillopharyngitis was 1.0% (9/1,014) and 15.0% (6/40) in school children with sore throat. Non-GAS exceeded GAS throat carriage and tonsillopharyngitis suggesting a yet underestimated role of non-GAS streptococci in BHS diseases.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Glycérol, ACS reagent, ≥99.5%
Sigma-Aldrich
Glycérol, for molecular biology, ≥99.0%
Sigma-Aldrich
Glycérol, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
D-sorbitol, ≥98% (GC)
Sigma-Aldrich
Glycérol solution, 83.5-89.5% (T)
Sigma-Aldrich
Glycérol, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
Glycérol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
D-sorbitol, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D-sorbitol, 99% (GC)
USP
Glycérine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-sorbitol, ≥98% (GC), for molecular biology
Sigma-Aldrich
Bacitracine, from Bacillus licheniformis, ≥65 IU/mg
Sigma-Aldrich
Glycérol, ≥99.5%
Sigma-Aldrich
Glycérol, FCC, FG
USP
D-sorbitol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-sorbitol, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
Bacitracine, from Bacillus licheniformis, ≥65 IU/mg
Supelco
Glycérol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Sorbitol F solution, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
Glycérol, BioXtra, ≥99% (GC)
Sigma-Aldrich
D-sorbitol, FCC, FG
Supelco
D-sorbitol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-sorbitol, ≥98% (GC), BioXtra
Sigma-Aldrich
Glycérine, meets USP testing specifications
Supelco
Glycérol, analytical standard
Sigma-Aldrich
Glycérol, tested according to Ph. Eur., anhydrous
Supelco
4,4′-DDT, PESTANAL®, analytical standard
D-sorbitol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-Pyroglutamic acid 2-naphthylamide, ≥99% (TLC)
Sigma-Aldrich
Glycérol, Vetec, reagent grade, 99%